The 24.8% relative risk reduction in prostate cancer seen in the finasteride arm prompted the early termination of the study on February 21, 2003, 15 months before its anticipated completion. While ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback